These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35979723)

  • 1. Single-stage, three-arm, adaptive test strategies for non-inferiority trials with an unstable reference.
    Brannath W; Scharpenberg M; Schmidt S
    Stat Med; 2022 Nov; 41(25):5033-5045. PubMed ID: 35979723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
    Scharpenberg M; Brannath W
    Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework for testing non-inferiority in a three-arm, sequential, multiple assignment randomized trial.
    Paul E; Chakraborty B; Sikorskii A; Ghosh S
    Stat Methods Med Res; 2024 Apr; 33(4):611-633. PubMed ID: 38400576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials.
    Meis J; Pilz M; Herrmann C; Bokelmann B; Rauch G; Kieser M
    Stat Med; 2023 Feb; 42(4):536-558. PubMed ID: 36577519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal group-sequential designs for simultaneous testing of superiority and non-inferiority.
    Ohrn F; Jennison C
    Stat Med; 2010 Mar; 29(7-8):743-59. PubMed ID: 19941286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conducting the non-inferiority test for the means with unknown coefficient of variation in a three-arm trial.
    Lee MC; Wu WY; Lu HY; Hsieh HN; Wu WH
    BMC Med Res Methodol; 2023 Aug; 23(1):183. PubMed ID: 37568109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage adaptive strategy for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Shih WJ; Quan H; Li G
    Stat Med; 2004 Sep; 23(18):2781-98. PubMed ID: 15344186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin.
    Schlömer P; Brannath W
    Stat Med; 2013 Dec; 32(28):4875-89. PubMed ID: 23970488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
    Li Z; Quartagno M; Böhringer S; van Geloven N
    Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
    Ghosh S; Paul E; Chowdhury S; Tiwari RC
    Biostatistics; 2022 Jan; 23(1):136-156. PubMed ID: 32385495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A more efficient three-arm non-inferiority test based on pooled estimators of the homogeneous variance.
    Lu H; Jin H; Zeng W
    Stat Methods Med Res; 2018 Aug; 27(8):2437-2446. PubMed ID: 27920362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning and analysis of three-arm non-inferiority trials with binary endpoints.
    Kieser M; Friede T
    Stat Med; 2007 Jan; 26(2):253-73. PubMed ID: 16685703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer.
    Sampayo-Cordero M; Miguel-Huguet B; Malfettone A; López-Miranda E; Gion M; Abad E; Alcalá-López D; Pérez-Escuredo J; Pérez-García JM; Llombart-Cussac A; Cortés J
    Front Oncol; 2023; 13():1048242. PubMed ID: 37496662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some practical considerations in three-arm non-inferiority trial design.
    Zhou M; Kundu S
    Pharm Stat; 2016 Nov; 15(6):550-559. PubMed ID: 27681603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T; Sampson AR; Gleser LJ
    Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analysis of a 3-arm noninferiority trial with a prespecified margin for the hazard ratio.
    Hida E; Tango T
    Pharm Stat; 2018 Sep; 17(5):489-503. PubMed ID: 29984524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
    Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
    BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.